Ocular Growth Factors Profile in Proliferative Retinopathies Before and After Intravitreal Bevacizumab
Clinical trial NCT00776763 · COMPLETED
Trial details
- NCT number
- NCT00776763
- Sponsor
- Ophthalmological Association Edelweiss
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-10-01
- Primary completion
- 2009-10-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.